PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test
Comprehensive Genetic Testing for Cardiac Myxoma Detection
The PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test represents a breakthrough in cardiac genetic diagnostics, offering precise detection of mutations associated with intracardiac myxomas. These rare but potentially serious cardiac tumors can lead to significant health complications if left undetected. Our advanced genetic testing provides crucial insights that enable proactive healthcare management and personalized treatment strategies.
What This Revolutionary Test Measures
This sophisticated genetic analysis specifically targets the PRKAR1A gene, which plays a critical role in regulating cell growth and division within cardiac tissues. The test utilizes Next-Generation Sequencing (NGS) technology to examine:
- Complete sequencing of the PRKAR1A gene coding regions
- Detection of point mutations, insertions, and deletions
- Identification of genetic variants associated with Carney Complex
- Assessment of inherited versus spontaneous mutations
- Comprehensive analysis of gene expression patterns
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Unexplained cardiac symptoms or arrhythmias
- Family history of cardiac myxomas or Carney Complex
- Multiple skin pigmentation abnormalities
- Endocrine disorders with cardiac manifestations
- Previous diagnosis of cardiac tumors requiring genetic confirmation
- Planning for family and concerned about genetic inheritance
Significant Benefits of Genetic Testing
Undergoing the PRKAR1A genetic test provides numerous advantages:
- Early Detection: Identify genetic predispositions before symptoms develop
- Personalized Treatment: Guide targeted therapeutic approaches
- Family Planning: Make informed decisions about genetic inheritance
- Proactive Monitoring: Implement appropriate screening protocols
- Peace of Mind: Reduce uncertainty about genetic risks
- Comprehensive Care: Coordinate with cardiologists and genetic specialists
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors:
- Positive Result: Indicates presence of PRKAR1A mutation, requiring specialized cardiac monitoring and potential preventive measures
- Negative Result: No detected mutation, though continued routine cardiac care is recommended
- Variant of Unknown Significance: Requires additional family studies and ongoing research correlation
- Comprehensive Report: Includes detailed analysis, clinical implications, and recommended follow-up actions
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Accessibility
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality genetic testing services nationwide.
Take Control of Your Cardiac Health Today
Don’t wait to understand your genetic predisposition to cardiac conditions. Our experienced genetic counselors and cardiac specialists are ready to guide you through the testing process and help interpret your results. Early detection through genetic testing can significantly impact your long-term cardiac health and quality of life.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test and take the first step toward comprehensive cardiac genetic health management.
Our dedicated team is available to answer your questions, discuss insurance coverage options, and help you understand the testing process from start to finish. With results typically available within 3-4 weeks, you’ll soon have the genetic information needed to make informed healthcare decisions.
